CIK 0001785530
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Werewolf Therapeutics, Inc.
Sign in to watch- Ticker
- HOWL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823523180
- Phone
- +1 617-952-0555
- Business address
- 303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-27 | EVNIN LUKE Director | Sale | −2,425 | $1.05 | $3K | 4,309,860 |
| 2025-03-27 | EVNIN LUKE Director | Option exercise · Warrant (Right to Buy) | −4,015 | 0 | ||
| 2025-03-27 | EVNIN LUKE Director | Option exercise · Warrant (Right to Buy) | −24,098 | 0 | ||
| 2025-03-27 | GADICKE ANSBERT 10% owner | Option exercise | +50,873 | $0.09 | $5K | 6,723,056 |
| 2025-03-27 | GADICKE ANSBERT 10% owner | Sale | −4,386 | $1.05 | $5K | 6,718,670 |
| 2025-03-27 | GADICKE ANSBERT 10% owner | Option exercise · Warrant (Right to Buy) | −8,031 | 0 | ||
| 2025-03-27 | GADICKE ANSBERT 10% owner | Option exercise · Warrant (Right to Buy) | −42,842 | 0 | ||
| 2025-02-19 | Singhal Anil K. Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2025-01-02 | Lubman Ellen Chief Business Officer | Grant or award · Stock Option (right to buy) | +131,900 | 131,900 | ||
| 2025-01-02 | Trost Timothy W. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2025-01-02 | Trost Timothy W. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +60,358 | 60,358 | ||
| 2025-01-02 | Isaacs Randi Chief Medical Officer | Grant or award · Stock Option (right to buy) | +187,500 | 187,500 | ||
| 2025-01-02 | Isaacs Randi Chief Medical Officer | Grant or award · Stock Option (right to buy) | +68,151 | 68,151 | ||
| 2025-01-02 | Karunatilake Chulani Chief Technology Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2025-01-02 | Karunatilake Chulani Chief Technology Officer | Grant or award · Stock Option (right to buy) | +153,129 | 153,129 | ||
| 2025-01-02 | HICKLIN DANIEL J | Grant or award · Stock Option (right to buy) | +592,690 | 592,690 | ||
| 2025-01-02 | HICKLIN DANIEL J | Grant or award · Stock Option (right to buy) | +185,652 | 185,652 | ||
| 2024-05-24 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2024-05-24 | DiRocco Derek Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2024-05-24 | Morrison Briggs Director | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 |
Page 10 of 17 · 335 trades